|
|
N/A
|
ACN12001-001
|
$270
|
$270
|
-, -
|
NASA/JPL JET PROPULSION LABORA
|
|
|
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
|
5R01CA215802-02
|
$511,546
|
$511,546
|
SPARREBOOM, ALEXANDER
|
OHIO STATE UNIVERSITY
|
|
|
(PQ 12) Targeting SMPDL3b to Prevent Radiation-Induced Nephrotoxicity
|
1R01CA227493-01
|
$427,990
|
$427,990
|
MARPLES, BRIAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
(PQ 5) Roles of mitochondrial heterogeneity in cell survival and oncogenesis
|
5R21CA216304-02
|
$195,750
|
$195,750
|
NEWMEYER, DONALD
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
|
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
|
5R01CA205965-02
|
$640,839
|
$640,839
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
|
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
|
5R01CA205954-03
|
$703,249
|
$703,249
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
|
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
|
5R01CA216054-02
|
$324,411
|
$324,411
|
HAYDEN GEPHART, MELANIE
|
STANFORD UNIVERSITY
|
|
|
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
|
5R01CA206483-02
|
$570,958
|
$570,958
|
EMU, BRINDA
|
YALE UNIVERSITY
|
|
|
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
|
1R01CA219871-01A1
|
$451,326
|
$451,326
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions
|
1R01CA227237-01
|
$686,519
|
$686,519
|
GUSEV, ALEXANDER
|
DANA-FARBER CANCER INST
|
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
5R01CA194461-04
|
$334,291
|
$334,291
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
|
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer
|
5R01CA216242-02
|
$319,238
|
$319,238
|
MACLEOD, KAY
|
UNIVERSITY OF CHICAGO
|
|
|
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
|
5R01CA217138-02
|
$723,817
|
$723,817
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
5R21CA216830-02
|
$192,500
|
$192,500
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
|
5R01CA206012-03
|
$403,884
|
$403,884
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
(PQ5) Role of Mitochondrial Division in Cancer Biology
|
5R01CA206005-03
|
$351,209
|
$351,209
|
CHIPUK, JERRY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
(PQA5) Dose and Mechanisms of Exercise in Breast Cancer Prevention
|
5R01CA179992-05
|
$648,503
|
$648,503
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-04
|
$446,627
|
$446,627
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
5R01CA194596-04
|
$525,066
|
$525,066
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
00005I-0140 NCI-OD -- 8422873
|
271201800005I
|
$43,698
|
$43,698
|
N/A
|
KELLY SERVICES INC
|
|
|
00007I-4739 NCI-OD -- 8422873
|
271201500007I
|
$24,553
|
$24,553
|
N/A
|
KELLY SERVICES INC
|
|
|
00012I-0329 NCI-OD -- 8422873
|
271201800012I
|
$137,572
|
$137,572
|
N/A
|
KELLY SERVICES INC
|
|
|
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048377-25
|
$39,000
|
$39,000
|
GADDE, KISHORE
|
LSU PENNINGTON BIOMEDICAL RESEARCH CTR
|
|
|
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048381-25
|
$68,181
|
$68,181
|
EHRMANN, DAVID
|
UNIVERSITY OF CHICAGO
|
|
|
03/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048468-25
|
$68,181
|
$68,181
|
FURLONG, KEVIN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048434-25
|
$68,181
|
$68,181
|
GOLDBERG, RONALD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
05/22 Diabetes Prevention Program Outcomes Study (DPPOS) - Phase 3 - Research Project
|
5U01DK048514-25
|
$68,181
|
$68,181
|
HAZUDA, HELEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
|
06/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048375-25
|
$68,181
|
$68,181
|
DABELEA, DANA
|
UNIVERSITY OF COLORADO DENVER
|
|
|
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 - Research Project
|
5U01DK048437-25
|
$42,300
|
$42,300
|
MUNSHI, MEDHA
|
JOSLIN DIABETES CENTER
|
|
|
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048413-25
|
$68,181
|
$68,181
|
KAHN, STEVEN
|
SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
|
|
|
09/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048411-25
|
$58,181
|
$58,181
|
DAGOGO-JACK, SAMUEL
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
|
10/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3- Research Project
|
5U01DK048380-25
|
$68,181
|
$68,181
|
MOLITCH, MARK
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048397-25
|
$68,181
|
$68,181
|
NATHAN, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
13/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048404-25
|
$68,181
|
$68,181
|
PI-SUNYER, XAVIER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
14/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048406-25
|
$68,181
|
$68,181
|
MATHER, KIEREN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
15/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048387-25
|
$68,181
|
$68,181
|
MAGEE, MICHELLE
|
MEDSTAR HEALTH RESEARCH INSTITUTE
|
|
|
16/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048443-25
|
$68,181
|
$68,181
|
WATSON, KAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
17/22 DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS) PHASE 3 - RESEARCH PROJECT
|
5U01DK048400-25
|
$22,085
|
$22,085
|
BROWN, ANGELA
|
WASHINGTON UNIVERSITY
|
|
|
18/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Project
|
5U01DK048485-25
|
$68,181
|
$68,181
|
GOLDEN, SHERITA
|
JOHNS HOPKINS UNIVERSITY
|
|
|
19/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048407-25
|
$44,000
|
$44,000
|
SCHADE, DAVID
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048349-26
|
$68,181
|
$68,181
|
CRANDALL, JILL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
2017 Society for Integrative Oncology (SIO) 14th Annual International Conference
|
1R13CA224869-01
|
$5,000
|
$5,000
|
VICTORSON, DAVID
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
2018 Biomedical Engineering Society (BMES) Cellular and Molecular (CMBE) Conference
|
1R13EB025705-01
|
$3,000
|
$3,000
|
CHAHINE, NADEEN
|
BIOMEDICAL ENGINEERING SOCIETY
|
|
|
2018 SEER ADVANCED TOPICS FOR REGISTRY PROFESSIONALS WORKSHOP
|
261201800246P
|
$25,000
|
$25,000
|
ALLEN, NANCY
|
NATIONAL CANCER REGISTRAR'S ASSOCIATION
|
|
|
21/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048412-25
|
$68,181
|
$68,181
|
VENDITTI, ELIZABETH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center
|
5U01DK048489-25
|
$203,538
|
$203,538
|
TEMPROSA, MARINELLA
|
GEORGE WASHINGTON UNIVERSITY
|
|
|
3-Dimensional profile of circulating miRNA for early cancer detection
|
5R01CA188991-04
|
$303,506
|
$303,506
|
ZHONG, WENWAN
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
|
|
3D Models of Immunotherapy
|
5U01CA214369-02
|
$729,562
|
$729,562
|
MOONEY, DAVID
|
HARVARD UNIVERSITY
|
|
|
3D Prostate Histochemometry to Predict Disease Recurrence
|
5R01CA197516-03
|
$400,610
|
$400,610
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
|
4E-BP Mimetics as Chemical Probes for Studying Translational Control in Cancer
|
5R01CA202018-03
|
$354,563
|
$354,563
|
GARNER, AMANDA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Total relevant funding to Cancer for this search: $1,718,328,371
|
